Kilitch Drugs (India) Limited

BSE:524500 Stock Report

Market Cap: ₹5.7b

Kilitch Drugs (India) Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 524500?
Owner TypeNumber of SharesOwnership Percentage
State or Government233,8161.45%
General Public4,214,33026.2%
Individual Insiders5,004,83131.1%
Private Companies6,629,34241.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 3.2%.


Top Shareholders

Top 5 shareholders own 73.8% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
41.2%
Kilitch Company (Pharma) Limited
6,629,342₹2.4b0%no data
20.9%
Bhavin Mehta
3,364,184₹1.2b0%no data
7.09%
Mukund Mehta
1,140,647₹404.6m0%no data
3.11%
Dipak Shah
500,000₹177.3m0%no data
1.45%
Investor Education and Protection Fund (IEPF)
233,816₹82.9m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.